These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Structure-activity relationships associated with 3,4,5-triphenyl-1H-pyrazole-1-nonanoic acid, a nonprostanoid prostacyclin mimetic. Meanwell NA; Rosenfeld MJ; Wright JJ; Brassard CL; Buchanan JO; Federici ME; Fleming JS; Seiler SM J Med Chem; 1992 Jan; 35(2):389-97. PubMed ID: 1370696 [TBL] [Abstract][Full Text] [Related]
8. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor. Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526 [TBL] [Abstract][Full Text] [Related]
9. Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor. Merritt JE; Brown AM; Bund S; Cooper DG; Egan JW; Hallam TJ; Heagerty AM; Hickey DM; Kaumann AJ; Keen M Br J Pharmacol; 1991 Jan; 102(1):260-6. PubMed ID: 2043927 [TBL] [Abstract][Full Text] [Related]
10. A comparative study of PGI2 mimetics used clinically on the vasorelaxation of human pulmonary arteries and veins, role of the DP-receptor. Benyahia C; Boukais K; Gomez I; Silverstein A; Clapp L; Fabre A; Danel C; Leséche G; Longrois D; Norel X Prostaglandins Other Lipid Mediat; 2013 Dec; 107():48-55. PubMed ID: 23850788 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship between prostacyclin and its platelet receptor. Correlation of structure change and the platelet activity. Tsai AL; Wu KK Eicosanoids; 1989; 2(3):131-43. PubMed ID: 2517029 [TBL] [Abstract][Full Text] [Related]
12. Replacing the cyclohexene-linker of FR181157 leading to novel IP receptor agonists: orally active prostacyclin mimetics. Part 6. Tanaka A; Hattori K; Taniguchi K; Okitsu O; Tabuchi S; Nishio M; Nagakura Y; Maeda N; Murai H; Seki J Bioorg Med Chem Lett; 2006 Sep; 16(18):4861-4. PubMed ID: 16837197 [TBL] [Abstract][Full Text] [Related]
13. Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist. Whittle BJ; Silverstein AM; Mottola DM; Clapp LH Biochem Pharmacol; 2012 Jul; 84(1):68-75. PubMed ID: 22480736 [TBL] [Abstract][Full Text] [Related]
14. Non-prostanoid prostacyclin mimetics as neuronal stimulants in the rat: comparison of vagus nerve and NANC innervation of the colon. Rudd JA; Qian Ym; Tsui KK; Jones RL Br J Pharmacol; 2000 Feb; 129(4):782-90. PubMed ID: 10683203 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation. Meja KK; Barnes PJ; Giembycz MA Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541 [TBL] [Abstract][Full Text] [Related]
17. Desensitization of prostacyclin responsiveness in platelets. Apparent differences in the mechanism in vitro or in vivo. MacDermot J Biochem Pharmacol; 1986 Aug; 35(16):2645-9. PubMed ID: 2427086 [No Abstract] [Full Text] [Related]
18. Interaction between platelet receptor and iloprost isomers. Tsai AL; Vijjeswarapu H; Wu KK Biochim Biophys Acta; 1988 Jul; 942(2):220-6. PubMed ID: 2456096 [TBL] [Abstract][Full Text] [Related]
19. Loss of high-affinity prostacyclin receptors in platelets and the lack of prostaglandin-induced inhibition of platelet-stimulated thrombin generation in subjects with spinal cord injury. Kahn NN; Bauman WA; Sinha AK Proc Natl Acad Sci U S A; 1996 Jan; 93(1):245-9. PubMed ID: 8552614 [TBL] [Abstract][Full Text] [Related]
20. Internalization and down-regulation of the prostacyclin receptor in human platelets. Giovanazzi S; Accomazzo MR; Letari O; Oliva D; Nicosia S Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):71-7. PubMed ID: 9224631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]